Pharmacology

Action Mechanism of Action Reference
INHIBITOR Receptor protein-tyrosine kinase erbB-2 inhibitor PubMed PubMed DailyMed DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 4 D001943 ClinicalTrials
Neoplasms 4 D009369 ClinicalTrials
Breast Neoplasms 4 D001943 ClinicalTrials
Salivary Gland Neoplasms 2 D012468 ClinicalTrials
Stomach Neoplasms 2 D013274 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 2 D002289 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
Neoplasm Metastasis 2 D009362 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1018448-65-1
ChEMBL CHEMBL1743082
FDA SRS SE2KH7T06F
Guide to Pharmacology 6928